Stebėti
Alan J Thompson
Alan J Thompson
Professor of Clinical Neurology and Neurorehabilitation, University College London
Patvirtintas el. paštas ucl.ac.uk - Pagrindinis puslapis
Pavadinimas
Cituota
Cituota
Metai
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
CH Polman, SC Reingold, B Banwell, M Clanet, JA Cohen, M Filippi, ...
Annals of neurology 69 (2), 292-302, 2011
107522011
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis
WI McDonald, A Compston, G Edan, D Goodkin, HP Hartung, FD Lublin, ...
Annals of Neurology: Official Journal of the American Neurological …, 2001
92282001
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
CH Polman, SC Reingold, G Edan, M Filippi, HP Hartung, L Kappos, ...
Annals of Neurology: Official Journal of the American Neurological …, 2005
65442005
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
AJ Thompson, BL Banwell, F Barkhof, WM Carroll, T Coetzee, G Comi, ...
The Lancet Neurology 17 (2), 162-173, 2018
62622018
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10269), 99-111, 2021
51882021
Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016
M Naghavi, AA Abajobir, C Abbafati, KM Abbas, F Abd-Allah, SF Abera, ...
The lancet 390 (10100), 1151-1210, 2017
47352017
Defining the clinical course of multiple sclerosis: the 2013 revisions
FD Lublin, SC Reingold, JA Cohen, GR Cutter, PS Sørensen, ...
Neurology 83 (3), 278-286, 2014
35742014
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
PM Folegatti, KJ Ewer, PK Aley, B Angus, S Becker, ...
The Lancet 396 (10249), 467-478, 2020
27262020
Non-invasive mapping of connections between human thalamus and cortex using diffusion imaging
TEJ Behrens, H Johansen-Berg, MW Woolrich, SM Smith, ...
Nature neuroscience 6 (7), 750-757, 2003
26252003
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial
MN Ramasamy, AM Minassian, KJ Ewer, AL Flaxman, PM Folegatti, ...
The Lancet 396 (10267), 1979-1993, 2020
16342020
Atlas of multiple sclerosis 2013: a growing global problem with widespread inequity
P Browne, D Chandraratna, C Angood, H Tremlett, C Baker, BV Taylor, ...
Neurology 83 (11), 1022-1024, 2014
14772014
Development of a multiple sclerosis functional composite as a clinical trial outcome measure
GR Cutter, ML Baier, RA Rudick, DL Cookfair, JS Fischer, J Petkau, ...
Brain 122 (5), 871-882, 1999
14101999
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four …
M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...
The Lancet 397 (10277), 881-891, 2021
13072021
The multiple sclerosis impact scale (MSIS-29) a new patient-based outcome measure
J Hobart, D Lamping, R Fitzpatrick, A Riazi, A Thompson
Brain 124 (5), 962-973, 2001
11982001
A longitudinal study of abnormalities on MRI and disability from multiple sclerosis
PA Brex, O Ciccarelli, JI O'Riordan, M Sailer, AJ Thompson, DH Miller
New England Journal of Medicine 346 (3), 158-164, 2002
11932002
Neural correlates of motor recovery after stroke: a longitudinal fMRI study
NS Ward, MM Brown, AJ Thompson, RSJ Frackowiak
Brain 126 (11), 2476-2496, 2003
11912003
Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis
LK Fisniku, PA Brex, DR Altmann, KA Miszkiel, CE Benton, R Lanyon, ...
Brain 131 (3), 808-817, 2008
11722008
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
J Zajicek, P Fox, H Sanders, D Wright, J Vickery, A Nunn, A Thompson
The lancet 362 (9395), 1517-1526, 2003
10222003
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis
D Miller, F Barkhof, X Montalban, A Thompson, M Filippi
The Lancet Neurology 4 (5), 281-288, 2005
9412005
Measuring the impact of MS on walking ability: the 12-Item MS Walking Scale (MSWS-12)
JC Hobart, A Riazi, DL Lamping, R Fitzpatrick, AJ Thompson
Neurology 60 (1), 31-36, 2003
8882003
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20